CD44 and breast carcinoma: Using a large-scale loss-of-function screen, Marotta et al. identified 15 genes that are required for the proliferation of the breast cancer stem cell population characterized by the CD44+CD24− immunophenotype, and five of these genes facilitate STAT3 activation [20].